Found: 94
Select item for more details and to access through your institution.
Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The beneficial impact of metabolic dysfunction‐associated fatty liver disease on lenvatinib treatment in patients with non‐viral hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2023, v. 53, n. 2, p. 104, doi. 10.1111/hepr.13843
- By:
- Publication type:
- Article
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
- Published in:
- Hepatology Research, 2021, v. 51, n. 7, p. 796, doi. 10.1111/hepr.13669
- By:
- Publication type:
- Article
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. 527, doi. 10.1159/000525145
- By:
- Publication type:
- Article
Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comment on Chun et al, "A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases".
- Published in:
- 2020
- By:
- Publication type:
- letter
Is There an Optimal Choice in Refractory Colorectal Cancer? A Network Meta-Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5500, doi. 10.3390/ijms21155500
- By:
- Publication type:
- Article
Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 12, p. 4494, doi. 10.3390/ijms21124494
- By:
- Publication type:
- Article
BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 21, p. 5369, doi. 10.3390/ijms20215369
- By:
- Publication type:
- Article
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 6, p. 1503, doi. 10.3390/ijms20061503
- By:
- Publication type:
- Article
Lenvatinib versus sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1389, doi. 10.1111/liv.14817
- By:
- Publication type:
- Article
Understanding surrogate measures of overall survival after trans‐arterial chemoembolization of hepatocellular carcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 5, p. 891, doi. 10.1111/liv.14873
- By:
- Publication type:
- Article
Oxidative Molecular Mechanisms Underlying Liver Diseases: From Systems Biology to the Personalized Medicine.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2019, p. 1, doi. 10.1155/2019/7864316
- By:
- Publication type:
- Article
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231171574
- By:
- Publication type:
- Article
ASO Visual Abstract: Minimally Invasive Approach Provides Oncological Benefit in Patients with High Risk of Very Early Recurrence (VER) After Surgery for Intrahepatic Cholangiocarcinoma (iCCA).
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Minimally Invasive Approach Provides Oncological Benefit in Patients with High Risk of Very Early Recurrence (VER) After Surgery for Intrahepatic Cholangiocarcinoma (iCCA).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 4, p. 2557, doi. 10.1245/s10434-023-14807-3
- By:
- Publication type:
- Article
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02386-2
- By:
- Publication type:
- Article
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 1, p. 49, doi. 10.1038/s41416-024-02687-7
- By:
- Publication type:
- Article
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 12, p. 1783, doi. 10.1038/s41416-022-01738-1
- By:
- Publication type:
- Article
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study.
- Published in:
- World Journal of Surgical Oncology, 2019, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12957-019-1602-z
- By:
- Publication type:
- Article
Sarcopenia in gastric cancer: when the loss costs too much.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 4, p. 563, doi. 10.1007/s10120-017-0722-9
- By:
- Publication type:
- Article
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology.
- Published in:
- Oncology, 2024, v. 102, n. 2, p. 157, doi. 10.1159/000533406
- By:
- Publication type:
- Article
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients.
- Published in:
- Oncology, 2021, v. 99, n. 5, p. 292, doi. 10.1159/000512796
- By:
- Publication type:
- Article
ROS1 rearrangements are uncommon in biliary tract cancers.
- Published in:
- Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12179
- By:
- Publication type:
- Article
Prognostic Role of a New Inflammatory Index with Neutrophil-to-Lymphocyte Ratio and Lactate Dehydrogenase (CII: Colon Inflammatory Index) in Patients with Metastatic Colorectal Cancer: Results from the Randomized Italian Trial in Advanced Colorectal Cancer (ITACa) Study [Corrigendum]
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 541, doi. 10.2147/CMAR.S242995
- By:
- Publication type:
- Article
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum].
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 5123, doi. 10.2147/CMAR.S215110
- By:
- Publication type:
- Article
Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 4357, doi. 10.2147/CMAR.S198651
- By:
- Publication type:
- Article
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 14, p. 2733, doi. 10.1002/1878-0261.13256
- By:
- Publication type:
- Article
Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 12, p. 3665, doi. 10.1007/s00432-021-03602-w
- By:
- Publication type:
- Article
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 2, p. 403, doi. 10.1007/s00432-017-2556-6
- By:
- Publication type:
- Article
Validation and refinement of PROSASH model using the neutrophil-to-lymphocyte ratio in patients with HCC receiving sorafenib.
- Published in:
- Liver Cancer International, 2020, v. 1, n. 1, p. 6, doi. 10.1002/lci2.12
- By:
- Publication type:
- Article
Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study Results.
- Published in:
- Oncologist, 2017, v. 22, n. 8, p. 886, doi. 10.1634/theoncologist.2017-0206
- By:
- Publication type:
- Article
Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1128930
- By:
- Publication type:
- Article
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 10, p. 1317, doi. 10.1080/0284186X.2021.1953704
- By:
- Publication type:
- Article
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2018, p. 1, doi. 10.1155/2018/7512159
- By:
- Publication type:
- Article
<i>KRAS</i>, <i>BRAF</i> and <i>PIK3CA</i> Status in Squamous Cell Anal Carcinoma (SCAC).
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092071
- By:
- Publication type:
- Article
EGFR, HER-2 and KRAS in Canine Gastric Epithelial Tumors: A Potential Human Model?
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085388
- By:
- Publication type:
- Article
Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience.
- Published in:
- Endocrine (1355008X), 2021, v. 74, n. 3, p. 707, doi. 10.1007/s12020-021-02813-y
- By:
- Publication type:
- Article
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study.
- Published in:
- Scientific Reports, 2017, p. 42499, doi. 10.1038/srep42499
- By:
- Publication type:
- Article
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC).
- Published in:
- Scientific Reports, 2016, p. 37621, doi. 10.1038/srep37621
- By:
- Publication type:
- Article
Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 6, p. 780, doi. 10.3390/biom11060780
- By:
- Publication type:
- Article
Clustered protocadherins methylation alterations in cancer.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0695-0
- By:
- Publication type:
- Article
Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920958363
- By:
- Publication type:
- Article
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/8024124
- By:
- Publication type:
- Article